IM Cannabis Corp.
The research page contains a warning that has not been mapped to a supported model interpretation. The company research remains available, but the complete score is withheld until the warning is reviewed.
IMCC · Price history
Price at last available close
$0.83
−$1.65 (-66.33%) 1M
2026-10-28
Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.
Company & revenue
About IM Cannabis Corp.
Primary reporting period: 2025-12-31 · Research updated Oct 13, 2026. A research update is not a new financial filing.
Who they are
IM Cannabis Corp. specializes in the cultivation, production, and provision of medicinal cannabis goods throughout international markets such as Israel, Germany, and Canada. The company offers a range of cannabis products, including flowers and specifically formulated cannabis extracts, marketed under its IMC brand. Furthermore, it supplies dried flower, pre-rolled products, and compressed hashish via its WAGNERS and Highland Grow labels.
How they make money
IM Cannabis Corp. operates as an international medical cannabis company that generates revenue primarily through the cultivation, processing, and distribution of premium medical cannabis products. The company serves medical patients in Israel and Germany, leveraging its supply chain and regulatory expertise to provide standardized cannabis products to these markets.
Products & services
The company provides premium medical cannabis products, including dried flowers and oils, to patients in Israel and Germany.
Brands & revenue mix
The primary brand under which the company markets its medical cannabis products.
Separate brand revenue is not available in this research.Source
Revenue share is not unit sales or a best-seller ranking. Parent brands and included sub-brands can overlap; do not add overlapping rows.
Product / operating segments
No reconciled product or operating-segment revenue breakdown is available for the current research period. Company-wide revenue remains separate from segment disclosure.
Geographic revenue
No reconciled geographic revenue breakdown was confirmed for the current research period.
Customer concentration
The company's 2025 annual report discloses that it is subject to customer concentration risks, noting that a significant portion of its revenue is derived from a limited number of customers or distribution channels in its operating regions.
Suppliers, materials & equipment
- Third-party cultivators and processors — The company relies on various third-party suppliers for the cultivation and processing of cannabis products to meet demand in its operating markets.Source
Strengths
Sources
Company-specific research
Questions worth answering for IMCC
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
- •What is driving IMCC's revenue decline, and does the latest company filing suggest the weakness is temporary or structural?
- •Is IMCC's positive free cash flow repeatable, or is the current level being helped by temporary working-capital or spending changes?
- •Is IMCC's debt load manageable relative to cash generation, interest costs and upcoming maturities?
- •What specifically needs to improve for IMCC to reach sustainable profitability?
- •What future growth or profitability would be needed to justify IMCC's current valuation?
Essential Investment Snapshot
Market Cap
$507K
P/E Ratio
-0.1
EPS
$-18.37
52-Week High
$77.10
52-Week Low
$1.55
Beta
2.10
Shares Outstanding
604K
Total Debt
$9.7M
Dividend
No current dividend
Liquidation Value / Share
$-6.57
Momentum & Volatility Signals
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
Strong downward momentum
High movement
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Notices for IMCC
Detected from reported data — verify before acting.Elevated debt risk
Negative shareholder equity • Interest coverage is below 2x • Cash covers less than 20% of total debt
M&A headline · Sep 23, 2026
IM Cannabis Enters Non-Binding Agreement to Acquire 51% of Space Defense Innovations, Operating in the European Tactical UAS Market — This is a provider-linked headline, not an independently confirmed event. Check the article and company filings for the subject, proposed/completed status, and subsequent updates.
PRNewsWireReverse-split headline · Aug 18, 2026
IM Cannabis Announces Intention to Complete 30:1 Share Consolidation to Support Nasdaq Minimum Bid Price Compliance — This is a provider-linked headline, not an independently confirmed event. Check the article and company filings for the subject, proposed/completed status, and subsequent updates.
PRNewsWireCommunity Sentiment
0 active · 0 total callsNo personal call yet on IMCC.
Potential upside factors
- +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
- +Established presence in key medical cannabis markets (Israel and Germany).
- +Focus on premium medical cannabis product quality.
- +Positive free cash flow may provide capacity to invest in growth.
Potential downside factors
- −Debt risk (elevated): Negative shareholder equity.
- −Interest coverage is below 2x.
- −Cash covers less than 20% of total debt.
- −Regulatory and legislative changes in cannabis markets.
These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdownWas this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
Score Changes
Score changes will appear once more historical records are available.
Price vs. Value
Valuation unavailableCurrent Price
$0.84
Model Intrinsic Value
—
Difference
—
Margin of Safety
—
Intrinsic value is not currently available for this stock, so valuation can't be calculated.
Financial Charts
Revenue
Additional Metrics
Operating Cash Flow
Total Debt
Total Assets
Net Margin %
Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.
| Line Item | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $29.1M | $38.5M | $38.0M | $34.3M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Cost of Revenue | $25.1M | $31.7M | $32.1M | $27.4M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Gross Profit | $4.0M | $6.8M | $5.9M | $6.9M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Research & Development | $0.00 | $0.00 | $0.00 | $0.00 | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| SG&A Expenses | $8.8M | $9.1M | $9.3M | $13.4M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Operating Expenses | $11.6M | $15.0M | $13.1M | $15.9M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| EBITDA | -$5.9M | -$4.9M | -$4.3M | -$2.0M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Operating Income | -$7.6M | -$8.2M | -$7.2M | -$9.0M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Interest Expense | $3.4M | $1.9M | $3.1M | $2.6M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Income Before Tax | -$11.5M | -$8.2M | -$9.0M | -$6.7M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Income Tax Expense | $40K | $65K | -$720K | $542K | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Net Income | -$11.1M | -$8.0M | -$7.4M | -$6.7M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Basic EPS | $-24.18 | $-56.36 | $-95.20 | $-93.93 | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Basic Shares | 9.27M | 141K | 78.3K | 71.2K | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Diluted Shares | 9.27M | 141K | 78.3K | 71.2K | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
Earnings Summary
Revenue
$5.3M
Estimate unavailable.
Revenue Beat/Miss
Not available (no estimate stored)
EPS
-$0.33
Estimate unavailable.
EPS Beat/Miss
Not available (no estimate stored)
Debt Change
-11.5%
Cash Change
+119.6%
Margin Change
-55.0 pp
Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.
Financial Changes Since Prior Period
What Improved
- Cash position grew
- Debt reduced
What Weakened
- Margins contracted
Potential Score Impact
Positive indicators included cash levels, debt levels. Pressure indicators included revenue growth, EPS growth, net income margin. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.
Stored Earnings Analysis
Revenue declined 40.2%. EPS declined 82.6%. Cash increased 119.6%. Total debt declined 11.5%. Net income margin declined by 55.0 percentage points.
Earnings-Call Transcript
Earnings-call transcript analysis is not currently available.
These results may influence future scores when the next evaluation is completed.
Insider Activity
Guru / Smart Money
Guru Score
Smart Money
Number of Gurus
Total Guru Value
Avg Portfolio Weight
Largest Holder
Largest Holder %
New Positions
Increased Positions
Reduced Positions
Exited Positions
Net Guru Sentiment
Short Interest
Dividend History
Dividend data is not available yet. Missing data does not mean this company pays no dividend.
Conservative Projected Values
3 Years
$———.——
5 Years
$———.——
10 Years
$———.——
Conservative Projection Rate
——%
Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.
Conservative Projected Values
Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.
Start 7-Day Free TrialHistorical Outperformance Record
Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.
Start 7-Day Free TrialHistorical Trends
4 historical recordsHistorical Score Chart
3 of 4 records shownWall Street Score
Debt Score
Revenue Score
Asset Score
Capital Score
Management Score
Moat Score
Valuation Score
Buffett Score
Intrinsic Value
Value Reference
Margin of Safety %
Related Companies
Drug Manufacturers - Specialty & GenericNews
IM Cannabis Announces Closing of the Sale of IMC Holdings and Its European-Focused Operations, Strengthens Balance Sheet
IM Cannabis Announces Closing of US$1.31 Million Registered Direct Offering of Common Shares
IM Cannabis Regains Compliance with Nasdaq Minimum Bid Price Requirement
IM Cannabis Announces Pricing of US$1.31 Million Registered Direct Offering of Common Shares
Rumor Mill · IMCC
Corporate developments & opportunities
No reviewed developments match this filter.
Evidence credibility is not a forecast of stock performance. Rumor Mill is separate from the WSS score.
Related Stock Research
Continue researching this company with related Wall Street Score rankings and investing guides.
Score Alerts
Premium unlocks alerts when a score rises, falls, or reaches your target price.
Start 7-Day Free TrialPortfolio Score
Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.
Start 7-Day Free Trial